Narrative Update • Aug 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedAug 12, 2026
DataAggregated Company Financials
Companies6
- 7D0.6%
- 3M-19.8%
- 1Y-29.6%
- YTDn/a
The Drug Retail is pretty flat in the last 7 days, but Lung Fung Group Holdings has stood out, gaining 8.8%. Unfortunately though, the industry is down 30% over the past 12 months. Earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 13 Aug 2026 | HK$203.8b | HK$143.8b | HK$8.8b | 31.6x | 23.3x | 1.4x |
| Sat, 11 Jul 2026 | HK$194.5b | HK$143.0b | HK$8.7b | 30.8x | 22.3x | 1.4x |
| Mon, 08 Jun 2026 | HK$201.6b | HK$143.2b | HK$8.7b | 34.1x | 23.1x | 1.4x |
| Wed, 06 May 2026 | HK$245.5b | HK$140.5b | HK$8.6b | 42.8x | 28.4x | 1.7x |
| Fri, 03 Apr 2026 | HK$263.4b | HK$139.1b | HK$8.5b | 46.7x | 30.8x | 1.9x |
| Sun, 01 Mar 2026 | HK$306.8b | HK$130.5b | HK$7.0b | 41x | 43.9x | 2.4x |
| Tue, 27 Jan 2026 | HK$356.7b | HK$128.2b | HK$6.9b | 50.3x | 51.9x | 2.8x |
| Thu, 25 Dec 2025 | HK$308.4b | HK$126.8b | HK$6.8b | 38.8x | 45.4x | 2.4x |
| Sat, 22 Nov 2025 | HK$326.6b | HK$122.6b | HK$6.2b | 57.2x | 53x | 2.7x |
| Mon, 20 Oct 2025 | HK$333.1b | HK$122.0b | HK$6.1b | 61.1x | 54.3x | 2.7x |
| Wed, 17 Sep 2025 | HK$371.1b | HK$122.4b | HK$6.2b | 68.6x | 60.3x | 3x |
| Fri, 15 Aug 2025 | HK$298.4b | HK$115.4b | HK$4.5b | 52.2x | 66.2x | 2.6x |
| Sun, 13 Jul 2025 | HK$237.3b | HK$115.5b | HK$4.5b | 44.9x | 52.6x | 2.1x |
| Tue, 10 Jun 2025 | HK$231.7b | HK$115.3b | HK$4.5b | 48.1x | 51.4x | 2x |
| Thu, 08 May 2025 | HK$230.2b | HK$110.9b | HK$4.2b | 63.7x | 55x | 2.1x |
| Sat, 05 Apr 2025 | HK$207.9b | HK$110.2b | HK$4.2b | 59.4x | 50x | 1.9x |
| Mon, 03 Mar 2025 | HK$210.4b | HK$103.8b | HK$3.6b | 50.6x | 58.6x | 2x |
| Wed, 29 Jan 2025 | HK$178.0b | HK$104.4b | HK$3.6b | 40.6x | 49.2x | 1.7x |
| Fri, 27 Dec 2024 | HK$162.9b | HK$103.4b | HK$3.6b | 38.9x | 45.5x | 1.6x |
| Sun, 24 Nov 2024 | HK$164.8b | HK$104.4b | HK$3.6b | 37.5x | 45.6x | 1.6x |
| Tue, 22 Oct 2024 | HK$169.8b | HK$104.7b | HK$3.3b | 48.2x | 51.1x | 1.6x |
| Thu, 19 Sep 2024 | HK$135.4b | HK$105.3b | HK$3.3b | 36.5x | 40.6x | 1.3x |
| Sat, 17 Aug 2024 | HK$133.7b | HK$104.5b | HK$2.9b | 36.4x | 45.6x | 1.3x |
| Mon, 15 Jul 2024 | HK$144.1b | HK$102.1b | HK$2.4b | 43.7x | 60.3x | 1.4x |
| Wed, 12 Jun 2024 | HK$161.7b | HK$102.1b | HK$2.4b | 49.3x | 67.6x | 1.6x |
| Fri, 10 May 2024 | HK$166.0b | HK$103.8b | HK$2.3b | 49.4x | 71.2x | 1.6x |
| Sun, 07 Apr 2024 | HK$144.3b | HK$103.9b | HK$2.3b | 42.9x | 61.9x | 1.4x |
| Tue, 05 Mar 2024 | HK$173.1b | HK$105.0b | -HK$1,455,361,607.11 | 57.7x | -118.9x | 1.6x |
| Thu, 01 Feb 2024 | HK$146.9b | HK$106.4b | -HK$1,475,003,437.00 | 47.1x | -99.6x | 1.4x |
| Sat, 30 Dec 2023 | HK$209.8b | HK$106.4b | -HK$1,474,562,979.00 | 64.8x | -142.3x | 2x |
| Mon, 27 Nov 2023 | HK$215.4b | HK$103.8b | -HK$1,768,893,170.00 | 86.5x | -121.8x | 2.1x |
| Wed, 25 Oct 2023 | HK$195.6b | HK$101.8b | -HK$1,736,192,909.00 | 81.8x | -112.7x | 1.9x |
| Fri, 22 Sep 2023 | HK$224.1b | HK$102.3b | -HK$1,674,631,750.00 | 101.5x | -133.8x | 2.2x |
| Sun, 20 Aug 2023 | HK$221.7b | HK$102.5b | -HK$2,688,312,394.00 | 72.5x | -82.5x | 2.2x |
Price to Earnings Ratio
-82.5x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.3x which is lower than its 3-year average PE of 100x.
- The 3-year average PS ratio of 1.9x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 12% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | -0.22% | |
| Consumer Staples | 0.54% | |
| Food and Staples Retail | 0.0051% | |
| Drug Retail | 0.56% | |
| Big Box Super Stores | 1.54% | |
| Food Distributors | -0.27% | |
| Food Retail | -1.07% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2290 Lung Fung Group Holdings | HK$3.70 | 8.8% +HK$150.0m | n/a | PE6.9x |